Ukraine secures 12 million AstraZeneca, Novavax COVID-19 vaccine doses: Zelenskiy

Fri, 05th Feb 2021 15:34

KYIV, Feb 5 (Reuters) - Ukraine has secured, from the Serum
Institute of India, 12 million coronavirus vaccine doses
developed by AstraZeneca and Novavax, President
Volodymyr Zelenskiy's office said in a statement.
(Reporting by Pavel Polityuk; writing by Matthias Williams;
editing by John Stonestreet)

Related Shares

More News

Today 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

Today 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: